McKinley Carter Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
McKinley Carter Wealth Services's BMY Position: Q2 2023 in Review
McKinley Carter Wealth Services sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,123 shares — an estimated $216K sold.
McKinley Carter Wealth Services first reported a position in BMY in Q1 2018 and held it in 11 quarters. The position peaked at $427K in Q2 2021. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- McKinley Carter Wealth Services reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
- McKinley Carter Wealth Services sold 3,123 Bristol-Myers Squibb shares in Q2 2023, an estimated $216K.
- McKinley Carter Wealth Services first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 11 quarters.
- McKinley Carter Wealth Services's Bristol-Myers Squibb position peaked at $427K in Q2 2021.
- 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on McKinley Carter Wealth Services's 13F filing for Q2 2023, filed 3 Aug 2023.